Among the thoracic cancer cohort, only one patient exhibited concurrent high HRD score and SBS3, and this patient harbored a BRCA2 mutation that was classified as benign (T582P, clinvar variant accession VCV000037753.10) (Table 2 and Fig. 1). The gene discussed is BRCA2; the disease is thoracic cancer.